Clinical researches have shown that high serum Lp-PLA2 levels were more likely to have a coronary event in atherosclerosis, and Lp-PLA2 was used as a biomarker for predicting a patient's risk for coronary heart disease and ischemic stroke associated with atherosclerosis (24). This evidence concerns the gene PLA2G7 and atherosclerosis.